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stem cells derived from Müller cells into retinal
ganglion cells by inhibiting Notch signaling
Wei-tao Song, Xue-yong Zhang and Xiao-bo Xia*Abstract
Introduction: Retinal Müller cells exhibit the characteristics of retinal progenitor cells, and differentiate into
ganglion cells under certain conditions. However, the number of ganglion cells differentiated from retinal Müller
cells falls far short of therapeutic needs. This study aimed to develop a novel protocol to promote the
differentiation of retinal Müller cells into ganglion cells and explore the underlying signaling mechanisms.
Methods: Müller cells were isolated and purified from rat retina and induced to dedifferentiate into retinal stem
cells. Next the stem cells were transfected with lentivirus PGC-FU-GFP or lentivirus PGC-FU-Atoh7-GFP. In addition,
the stem cells were transfected with Brn-3b siRNA or Isl-1 siRNA or treated with Notch inhibitor gamma-secretase
inhibitor (GSI).
Results: The proportion of ganglion cells differentiated from Atoh7-tranfected stem cells was significantly higher
than that of controls. Knockdown of Brn-3b or Isl-1 inhibited, while GSI promoted, the differentiation into retinal
ganglion cells. Atoh7 promoted the expression of Brn-3b and Isl-1 but inhibited the expression of Notch1.
Conclusions: Atoh7 promotes the differentiation of Müller cells-derived retinal stem cells into retinal ganglion cells
by inhibiting Notch signaling, thus opening up a new avenue for gene therapy and optic nerve regeneration in
glaucoma.
Keywords: Müller cells, Retinal ganglion cells, Atoh7, Notch, Stem cells, DifferentiationIntroduction
Glaucoma is a group of eye diseases characterized by the
selective and progressive death of retinal ganglion cells,
which in turn, causes a severe loss in visual function. A
common treatment for glaucoma is the reduction of in-
traocular pressure (IOP), but this approach does not
prevent the visual loss caused by the death of retinal
ganglion cells (RGCs) [1,2]. In the late stage of glaucoma
as many as 90% of retinal ganglion cells could be dam-
aged. Numerous approaches have been developed to
provide protection to ganglion cells, such as improving
optic microcirculation, glutamate pathway inhibitors,
neurotrophic factors, induction of heat shock protein ex-
pression and antioxidant therapy [3-5]. However, no ef-
fective treatments can essentially prevent ganglion cells* Correspondence: xbxia21@163.com
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reproduction in any medium, provided the orand the optic nerve from being injured. Stem cells have
been proposed as a new approach for the regeneration
of ganglion cells [6,7]. However, retinal stem cells only
exist in the pigmented ciliary epithelium and they are far
too few to meet the clinical need [6]. On the other hand,
the use of other stem cells, such as embryonic stem cells
and neural stem cells, is greatly restricted due to ethical
issues and graft rejection. Therefore, it is urgent to iden-
tify new types of retina-derived cells that are abundant
in seed cells for the regeneration of ganglion cells.
Müller cells are the sole glia cells generated by retinal
stem cells/progenitors [8]. Müller cells extend from the
inner limiting membrane to the external membrane
throughout the entire retina. The neurites of Müller cells
are widely distributed in various types of neuronal cell
bodies in the retina, and make extensive contacts with
the retinal nerve neurons [9,10]. Extensive studies in re-
cent years have implicated retinal Müller cells astd. This is an Open Access article distributed under the terms of the Creative
ommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and
iginal work is properly cited.
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have been shown to induce the dedifferentiation of ret-
inal Müller cells in zebrafish, chickens and adult rats
[11-13]. These dedifferentiated retinal Müller cells ex-
hibit the characteristics of stem cells, and can differenti-
ate into neurons, including retinal ganglion cells.
However, the proportions of ganglion cells induced in
the above studies are too low to replace and compensate
the dead and damaged cells in glaucoma. Therefore,
strategies to enhance the differentiation of Müller cells
into ganglion cells may hold promise for glaucoma treat-
ment via optic nerve regeneration.
The induction and differentiation of retinal stem cells
are largely regulated by the joint action of extracellular
and intracellular factors. The family of transcription fac-
tors bHLH (basic helix-loop-helix) plays an important
regulatory role in the differentiation of retinal cells. The
vertebrate bHLH family includes the original nerve
(proneural) gene, the Ath family, Ash family and Hes
family for the antagonizing proneural gene [14]. Ath5 is
one member of the Ath family, and Atoh7 is an expres-
sion form of Ath5 in the rat, which is involved in the dif-
ferentiation of rat retinal ganglion cells. Atoh7 is an
essential transcription factor that determines the compe-
tence state of retinal ganglion cell progenitors [15,16].
Ectopic expression of Atoh7 significantly increased the
number of retinal ganglion cells differentiated from
in vitro cultured retinal stem cells [17]. Therefore, we
hypothesize that Atoh7 may also promote the differenti-
ation of stem cells dedifferentiated from retinal Müller
cells into ganglion cells.
The differentiation into retinal ganglion cells induced
by Atoh7 is a complicated process, in which various
kinds of genes and signal pathways interact. Recent stud-
ies have shown that Brn-3b, a downstream target gene
of Atoh7, and Isl-1, a member of LIM-HD family, could
synergize to promote the growth and differentiation of
rat retinal ganglion cells during the embryo period [18].
On the other hand, the Notch signaling pathway nega-
tively regulates the growth and differentiation of retinal
ganglion cells. It has been shown that downstream effec-
tors of Notch signaling regulate retinal ganglion cell dif-
ferentiation [19].
In this study, we cultured rat retinal Müller cells
in vitro and induced them to dedifferentiate into stem
cells with a stem cell-conditioned medium. Next, we ec-
topically expressed Atoh7 in these cells to induce them
to differentiate into ganglion cells. In addition, we inter-
fered with the expression or activity of Brn-3b, Isl-1 and
Notch1 in rat retinal stem cells, and examined the ef-
fects on their differentiation into ganglion cells, in order
to explore the signaling mechanisms that regulate the
re-differentiation of stem cells derived from Müller cells
into ganglion cells.Material and methods
Ethics statement
The use of animals in this study was in accordance with
the Guidelines for Animal Experiments of Central South
University, Changsha, China. All animal experiments
in this study were conducted with the approval of the
Animal Research Committee, Xiangya School of Medicine,
Central South University, Changsha, China (Permit No.
SCXK 2006–0002).
Müller cell culture
The enrichment of the Müller cells was performed as
previously described [11]. Briefly, the eyes from Day 21
Sprague Dawley (SD) rats were enucleated and washed
several times with a phosphate-buffered solution (PBS)
(Gibco: Grand Island, NY, USA). The retinae were dis-
sected carefully to avoid contamination from the lens,
the retinal pigment epithelium (RPE) and the ciliary epi-
thelium. The retina was mechanically dissociated into
small aggregates and trypsinized with 0.25% trypsin-
EDTA (Sigma: St. Louis, MO, USA) in a 37°C incubator
for 20 minutes. The digested retina was suspended in
DMEM containing 20% FBS and 1:100 penicillin/
streptomycin (Sigma), and inoculated in a 25 cm2 cul-
ture flask (Corning: Corning city, NY, USA) for five to
seven days, until the Müller cells attached to the bottom
of the flask. The cells were trypsinized and cultured in
DMEM containing 20% FBS for six days to further purify
the Müller cell population. Cells of the third passage
were dissociated with 0.25% trypsin-EDTA and cultured
in a serum-free dedifferentiation media containing
DMEM/F12 (GIBCO), 1 × N2 supplement (GIBCO), 2 ×
B27 supplement (GIBCO), 20 ng/ml EGF (Peprotech: Rocky
Hill, NJ, USA), 10 ng/ml bFGF (Peprotech), 2 mM L-
glutamine (HyClone: Logan, UT, USA), 100 U/ml penicillin
and 100 μg/ml streptomycin at a density of 1 × 105 cells/cm2
for five to seven days to generate neurospheres. Half of the
dedifferentiation media was changed every other day. The
suspended and semi-suspended neurospheres were collected
and dissociated with Accutase (Sigma), and then cultured in
serum-free dedifferentiation media to obtain a purified
generation.
Immunohistochemical analysis
Immunocytochemical analysis was performed as previ-
ously described [20]. Briefly, 4% paraformaldehyde-fixed
cells were incubated in PBS containing 3% bovine serum
albumin (BSA), 5% goat serum and 0.3% TritonX-100 at
37°C for 1 h, followed by incubation at 4°C overnight
with the primary antibodies listed in Table 1. The cells
were then incubated in the dark at room temperature
for 1 h with secondary antibodies anti-rabbit IgG conju-
gated with FITC (Sigma), anti-mouse IgG conjugated
with FITC (Sigma), anti-rabbit IgG conjugated with
Table 1 List of antibodies used in this study
Antibodies Species Dilution Cell markers Company
GS Rabbit 1:200 Müller cells Sigma
Pax6 Rabbit 1:100 Retina stem cells Santa Cruz
Nestin Mouse 1:100 Retina stem cells Abcam
Notch1 Mouse 1:200 Retina stem cells Sigma
Sox2 Rabbit 1:100 Retina stem cells Sigma
Thy1.1 Rabbit 1:200 RGCs Sigma
Brn-3b Rabbit 1:300 RGCs Santa Cruz
PKC Rabbit 1:200 Bipolar cells Sigma
Rhodopsin Mouse 1:200 Photoreceptor cells Abcam
HPC-1 Rabbit 1:200 Amacrine cells Sigma
calbindin Rabbit 1:100 Horizontal cells Sigma
Edu Rat 1:1,000 Retina stem cells RiboBio
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TRITC (Sigma). Finally, the cells were incubated with
DAPI (Beyotime: Shanghai. China) for five minutes and
images were captured using fluorescent microscopy
(Leica: Solms, Germany).FACS analysis
The purity of the enriched Müller cells was examined by
fluorescence-activated cell sorting (FACS) analysis using
antibodies specific to Müller cells. Briefly, the cells in
the monolayer culture were dissociated into single cells
by the method of passage and centrifugation. The cells
were fixed with 4% paraformaldehyde and blocked with
a PBS containing 1% BSA and 0.1% TritonX-100 for 30
minutes at 4°C, then incubated at 4°C for 1 h with the
primary antibodies listed in Table 1. After that, the cells
were incubated in a PBS-BSA solution containing the
appropriate secondary antibodies linked to FITC at 4°C
for 1 h in the dark. The cells were washed with PBS and
re-suspended in PBS for FACS analysis.Edu labeling analysis
To evaluate the proliferation of stem cells, neurospheres
were incubated with 1:1,000 Edu (RiboBio: Guangzhou,
Guangdong, China) diluted in culture solution overnight
at 37°C. After several washes, the cells were fixed with
4% paraformaldehyde for 30 minutes. Fixed cells were
incubated with an Apollo buffer (RiboBio) for 30 mi-
nutes at room temperature in the dark. The cells were
washed with 0.5% TrixtonX-100 (diluted in PBS) for 10
minutes, followed by staining with Hoechst 33342
(RiboBio: Guangzhou, Guangdong, China) at room
temperature for 30 minutes in the dark. Images were
captured using fluorescent microscopy.Lentivirus PGC-FU-Atoh7-GFP constructs and transfection
Atoh7 expression vector Lentivirus PGC-FU-Atoh7-
IRES-GFP was constructed by GENECHEM (Shanghai,
China). The neurosphere cells were transfected with the
lentivirus at the multiplicity of infection (MOI) of 10
and the efficiency of transfection was detected by FACS.
Neurospheres dedifferentiated from Müller cells were
divided into three groups: Group A: neurospheres
transfected by PGC-FU-Atoh7-GFP; Group B: neurospheres
transfected by empty vector PGC-FU-GFP; and Group
C: neurospheres without transfection. After transfec-
tion, the cells were plated onto 0.01% poly-D-lysine
(Sigma)-coated 24-mm coverslips (Corning) at a con-
centration of 1 × 104 cells/well, and cultured in 1 ml dif-
ferentiation medium supplemented with brain-derived
neurotrophic factor (BDNF: brain-derived neurotrophic
factor) (1 ng/ml) (Peprotech), RA (1 μM) (Sigma) and
1% FBS at 37°C in a 5% CO2 incubator, and the medium
was changed 48 h after plating to remove debris. There-
after, the cells were fed every two days by replacing one
third of the differentiation medium. At days 7 and 14,
the cells were fixed by cold 4% paraformaldehyde for
immunocytochemical analysis to calculate the percent-
age of ganglion cells.
Interference of Brn-3bsiRNA, Isl-1siRNA and Notch signal
pathway inhibitor
The purified neurospheres were collected and dissoci-
ated with Accutase: Sigma, St. Louis, MO, USA, and the
stem cells were seeded into six-well culture plates at a
density of 1 × 105 cells/well, and cultured in 2 ml differen-
tiation medium supplemented with BDNF (1 ng/ml), RA:
retinoic acid (1 μM) and 1% FBS. The cells were ran-
domly divided into groups as follows: Group a1: Brn-3b
siRNA group (sc-38767), Group a2: Control siRNA
group (scrambled sequence, sc-37007), Group a3: Con-
trol group (without any handling); Group b1: Isl-1
siRNA group (sc-37122), Group b2: Control siRNA
group (scrambled sequence, sc-44230), Group b3: Con-
trol group (without any handling); Group c1: Notch sig-
nal pathway inhibitor (GSI) group (sc-221656), Group
c2: Control group (without any handling). The stem
cells were transfected with the indicated siRNA or
treated with GSI. After 72 h, the cells were transfected
with lentivirus PGC-FU- Atoh7-GFP. At seven days
after transfection, immunofluorescence staining was
performed to detect the percentage of ganglion cells in
total differentiated cells.
RT-PCR analysis
Total RNA was isolated from cells using Trizol: Sigma,
St. Louis, MO, USA reagent according to the manufac-
turer’s protocol, and reverse transcribed to cDNA. PCR
reaction was performed in a 20 μl volume containing
Table 2 List of primers used in this study
Name Sequence Annealing temp (°C) Size (bp) Acc. no
Glutamine synthetase Forward: 5′TCACAGGGACAAATGCCGAG3′ 58 362 M96152
Reverse: 5′GTTGATGTTGGAGGTTTCGTGG3′
Vimentin Forward: 5′AAGGCACTAATGAGTCCCTGGAG3′ 56 251 NM031140
Reverse: 5′GTTTGGAAGAGGCAGAGAAATCC3′
CRALBP Forward: 5′CTGAGTTTGGAGGAATCTTGC3′ 54 150 XM217702
Reverse: 5′TGGATTTGGGGGAGAGTTC3′
Clusterin Forward: 5′CCTCCAGTCCAAGATGCTCAAC3′ 58 292 NM_053021
Reverse: 5′TTTCCTGCGGTATTCCTGTAGC3′
Carbonic anhydrase Forward: 5′TTGCCAATGGAGACCGACAG3′ 58 233 NM_019291
Reverse: 5′TGAGCCCCAGTGAAAGTGAAAC3′
Opsin Forward: 5′CATGCAGTGTTCATGTGGGA 3′ 64 422 U22180
Reverse: 5′AGCAGAGGCTGGTGAGCATG 3′
mGluR6 Forward: 5′CACAGCGTGATTGACTACGAG3′ 56 317 D13963
Reverse: 5′CTCAGGCTCAGTGACACAGTTAG3′
HPC1 Forward: 5′AAGAGCATCGAGCAGCAGAGCATC3′ 60 342 NM016801
Reverse: 5′CATGGCCATGTCCATGAACAT3′
Brn-3b Forward: 5′GGCTGGAGGAAGCAGAGAAATC 3′ 60 141 AF390076
Reverse: 5′TTGGCTGGATGGCGAAGTAG 3′
CD31 Forward: 5′AAGAGCAACTTCCAGACCGTCC 3′ 58 222 NM_031591
Reverse: 5′AAGCACCATTTCATCTCCAGACTG 3′
Tyrosinase Forward: 5′TCAGTCTATGTCATCCCCACAGG3′ 56 252 NM_011661
Reverse: 5′GTTCTCATCCCCAGTTAGTTCTCG3′
Nestin Forward: 5′TGGAGCAGGAGAAGCAAGGTCTAC3′ 56 295 NM012987
Reverse: 5′TCAAGGGTATTAGGCAAGGGGG3′
Pax6 Forward: 5′CCATCTTTGCTTGGGAAATCC3′ 56 310 NM_013001
Reverse: 5′TCATCCGAGTCTTCTCCATTGG3′
Atoh7 Forward: 5′ATGAAGTCGGCCTGCAAAC3′ 55 389 AF_071223
Reverse: 5′GGGTCTACCTGGAGCCTAGC3′
Notch1 Forward: 5′TCTGGACAAGATTGATGGCTACG3′ 56 329 NM008714
Reverse: 5′CGTTGACACAAGGGTTGGACTC3′
β-Actin Forward: 5′GTGGGGCGCCCCAGGCACCA 3′ 50 548 XM_037235
Reverse: 5′ CTCCTTAATGTCACGCACGATTTC 3′
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forward primer and reverse primer (the primers were
listed in Table 2), 2 μl diluted cDNA and 6 μl double-
distilled H2O. Amplification conditions were as follows:
15 sec at 95°C (one cycle); 5 sec at 95°C, 5 sec at
annealing temperature and 30 sec at 72°C (45 cycles).
The results were analyzed by ABIViia7: ABI, Foster
City, CA, USA.
Western blot analysis
Proteins were extracted from the cells by using Radio
Immuno Precipitation Assay (RIPA: RiboBio: Guangzhou,Guangdong, China) buffer containing 1:100 protease
inhibitor and 1:100 phosphatase inhibitor. The protein
concentration was determined by using a microplate
reader. Lysates were separated on SDS-PAGE and
transferred onto polyvinylidene fluoride (PVDF) mem-
branes. The membranes were blocked with 5% nonfat
milk in TBS plus 0.1% Tween (TBS-T) for 1 h, then in-
cubated with primary antibodies for 1 h at room
temperature. After several washes, the membranes
were incubated with HRP-conjugated secondary anti-
bodies for 1 h. Blots were visualized with ECL:
Enhanced Chemiluminescence buffer.
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All data were expressed as the mean ± SD. Statis-
tical analysis was performed with one-way ANOVA
and Student’s t- test using SPSS: Chicago, IL, USA
13.0. P <0.05 was considered significant.
Results
Purification and morphological characteristics of Müller cells
After the dissociated and trypsinized retinal tissues were
filtrated by a 200-mesh filter, retinal cells were inocu-
lated in a 25 cm2 culture flask. About 72 h later, we
found that some of retinal cells attached to the bottom
of the flask. The cells initially appeared to be cell aggre-
gates, single cells or debris. After five to seven days ofFigure 1 Purity of enriched Müller cells. Rat retinal Müller cells were enr
Scale bar: 100 μm. Immunocytochemical and FACS analysis showed that m
marker GS (C, D). Scale bar: 100 μm. The purity of enriched cells was evalu
transcripts (E) and other cell type specific transcripts (F). Lane M: DNA mar
activated cell sorting.culture, numerous bipolar spindle-shaped cells were ob-
served on the surface of the flask. At 8 to 10 days, the
cell culture medium became light yellow and the culture
medium was replaced every 2 to 3 days; both aggregated
and loosely attached materials were discarded, leaving
only tightly adherent cells on the flask surface. As the
adherent cells proliferated, they became increasingly
flattened and epithelioid shaped. When the proliferated
cells formed a complete confluent monolayer of epi-
thelioid cells (Figure 1A), the cells were trypsinized
and subcultured in DMEM containing 20% FBS for
another five to six days to obtain a further purified
Müller cell population. After the fourth passage, these
cells were the same size and shape, and had abundantiched and passaged to obtain a highly purified cell population (A, B).
ore than 98% of purified cells were immunoreactive to Müller cell
ated by RT-PCR analysis to detect the expression of Müller cell specific
ker; lane 1: PN21 retina; lane 2: purified Müller cells. FACS, fluorescence-
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To determine whether the cultured cells were Müller
cells, we chose the cells in the fourth passage to examine
immunoreactivity for glutamine synthetase (GS) (Müller
cell specific markers) [21]. The results showed that
98.10 ± 2.18% of the cells in the monolayer culture
were immunoreactive for GS (Figure 1C). To further
determine the purity of Müller cell culture, we carried
out FACS and RT-PCR analysis. FACS showed that
98.01% of purified cells were immunoreactive for GS
(Figure 1D). RT-PCR analysis revealed that cells in
the culture expressed a battery of transcripts charac-
teristic of Müller cells, such as GS, vimentin, cellular
retinaldehyde-binding protein (CRALBP), clusterin and
carbonic anhydrase [9,22] (Figure 1E). In contrast, the
transcripts corresponding to rod photoreceptors (opsin),
bipolar cells (mGluR6), amacrine cells (Syntaxin 1), retinal
ganglion cells or RCGs (Brn3b), endothelial cells (CD31)
and retinal pigmented epithelium (RPE)/pigmented ciliary
epithelium (tyrosinase) were not detected, suggesting thatFigure 2 Stem cell properties of enriched Müller cells. Enriched Müller
neurospheres (A, B). The neurospheres were passaged to get new clonal n
cells within the cell spheres had positive expression of retinal stem cell-spe
Immunocytochemical analysis of Edu showed that newborn cell spheres h
bar: 100 μm. RT-PCR and Western blot analysis to detect the expression of
Müller cells; lane 2: neurospheres.the monolayer culture was enriched with Müller cells
and not contaminated with the above mentioned cells
(Figure 1F). However, low levels of transcripts characteris-
tic of microglia (Iba1) were detected, suggesting the pre-
sence of microglia in the enriched Müller cell culture.
Dedifferentiation of purified Müller cells into retinal stem
cells
The purified Müller cells were cultured in stem cell-
conditioned medium for three days, some cells under-
went apoptosis, some cell processes became smaller
and the cell body became round. The proliferation
was clonal, and a few spherical or mulberry-shaped
cell spheres composed of dozens of cells appeared
(Figure 2A). At five to seven days of culture, the cell
spheres increased in both number and size, cells displayed
good refraction and exhibited well-defined cell boundaries
at the edge of cell spheres and the cell spheres became fur-
ther rounded, resembling neurospheres (Figure 2B).
Thereafter, the cell spheres showed no significant increasecells exposed to the stem cell-conditioned medium formed
eurospheres (C). Immunofluorescence staining showed that the stem
cific markers Nestin (92.94 ± 6.48%) and Pax6 (85.96 ± 6.04%) (D, F).
ad the capacity of effective proliferation (82.80 ± 6.65%) (E, F). Scale
stem cell markers Nestin and Pax6 (G, H). Lane M: DNA marker; lane 1:
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were collected and dissociated into single stem cells which
were cultured in serum-free dedifferentiation media to
generate new clonal neurospheres (Figure 2C). Immuno-
fluorescence staining showed that stem cells within the
spheres were positive for retinal stem cell-specific markers
Nestin (green fluorescence, 92.94 ± 6.48%) and Pax6 (red
fluorescence, 85.96 ± 6.04%) (Figure 2D, F), suggesting
that retinal Müller cells can dedifferentiate into retinal
stem cells in the conditioned medium. Meanwhile, Edu
staining showed that most of the nuclei within the cell
spheres were stained red (82.80 ± 6.65%), suggesting that
the new cell spheres have the capacity for effective prolif-
eration (Figure 2E, F). RT-PCR analysis showed that cell
spheres in the culture expressed a battery of transcripts
characteristic of stem cells, such as Nestin and Pax6,
which were absent in the Müller cells (Figure 2G). West-
ern blot analysis further confirmed the expression of
Nestin and Pax6 in the cell spheres but not in the Müller
cells (Figure 2H). Taken together, these data suggest that
Müller cells were dedifferentiated into retinal stem cells.
Atoh7 promotes the differentiation of Müller
cells-derived stem cells into ganglion cells
Next, stem cells dedifferentiated from Müller cells were
transfected with lentivirus PGC-FU- Atoh7-GFP or
empty vector PGC-FU-GFP. After 48 h, the number of
GFP labeled cells increased and fluorescence intensity
was enhanced and distributed homogeneously in the
cytoplasm (Figure 3A). FACS analysis showed that the
transfection efficiency was 75.41% (Figure 3B). At this
time, the neurosphere cells of the three groups were sep-
arated into single cells by Accutase and green fluores-
cence could be seen perspicuously in the single cells
using fluorescent microscopy (Figure 3C).
After culture of the single cells in differentiation
medium for seven days, immunocytochemical analysis
was performed to calculate the percentage of the gan-
glion cells, which were positive for Thy1.1 (green fluor-
escence) and Brn-3b (red fluorescence) (Figure 3D). The
percentage of ganglion cells was similar between cells
transfected with PGC-FU-GFP and cells untransfected
(13.3 ± 13.25% versus 9.10 ± 3.21%), significantly lower
than that in cells transfected with PGC-FU-Atoh7-GFP
(50.40 ± 8.22%) (Figure 3E). Collectively, our results in-
dicate that Atoh7 promotes the differentiation of Müller
cells-derived stem cells into ganglion cells.
At 14 days after transfection, the cells were examined
again for ganglion cell-specific markers. Immunocyto-
chemical analysis showed that the percentage of gan-
glion cells was 8.40 ± 2.32% (Group B), 8.20 ± 3.19%
(Group C) and 49.90 ± 10.16% (Group A) (Figure 3F).
These results showed that at 7 and 14 days, the effi-
ciency of Atoh7 to promote the differentiation of retinalstem cells into retinal ganglion cells was similar (50.40 ±
8.22% versus 49.90 ± 10.16%). Apart from ganglion cells,
retinal stem cells derived from Müller cells were differ-
entiated into other types of cells, such as amacrine cells,
horizontal cells, bipolar cells, photoreceptor cells and
Müller cells (Figure 3G-I).
RT-PCR and Western blot analysis showed that the ex-
pression of Atoh7, Brn-3b and Isl-1 at both mRNA and
protein levels were increased on 0 day, 1 day, 3 days, 7
days and 14 days after transfection with PGC-FU-Atoh7-
GFP, but the expression of Notch1 was slightly reduced.
The control group (the cell spheres with no transfection)
showed no significant differences in mRNA and protein ex-
pression of Atoh7, Brn-3b, Isl-1 and Notch1 (Figure 3J, K).
These data suggest that Atoh7 regulates the expression of
Brn-3b, Isl-1 and Notch1 in retinal stem cells.
Effects of Brn-3bsiRNA, Isl-1siRNA and Notch inhibitor on
the differentiation of Müller cells-derived stem cells into
ganglion cells
To explore the signaling mechanisms by which Atoh7
promotes the differentiation of Müller cells-derived stem
cells into ganglion cells, we treated retinal stem cells
with Brn-3b siRNA, Isl-1 siRNA or gamma-secretase in-
hibitors (GSI). After 72 h, the stem cells were transfected
by PGC-FU-Atoh7-GFP. After seven days, the cells in
each group were evaluated for ganglion cell-specific
markers. The percentages of ganglion cells were as fol-
lows: 23.30 ± 4.45% (Group a1), 50.60 ± 7.04% (Group
a2) and 49.70 ± 7.36% (Group a3) (Figure 4A); 25.90 ±
3.35% (Group b1), 49.9 ± 5.38% (Group b2) and 49.2 ±
4.64% (Group b3) (Figure 4B); 58.2 ± 6.46% (Group c1)
and 49.4 ± 5.78% (Group c2) (Figure 4C). These results
showed that knockdown of Brn-3b or Isl-1 could inhibit
the differentiation of Müller cells-derived stem cells into
retinal ganglion cells, while the Notch signal pathway in-
hibitor was able to promote the differentiation into ret-
inal ganglion cells. In addition, Atoh7 and GSI exhibited
synergistic effects to promote the differentiation of
Müller cells-derived stem cells into retinal ganglion cells
(between Group c1 and Group a3, b3; F = 6.533, P = 0.005;
Figure 4D).
RT-PCR and Western blot analysis showed that the
expression of Brn-3b, Isl-1 and Notch1 was reduced
in the Brn-3b siRNA group, the Isl-1 siRNA group and
the GSI group, respectively. In addition, Atoh7 and GSI
synergistically inhibited the expression of Notch1
(Figures 4E and 5).
Discussion
Glaucoma is a complex, multivariate, irreversible blinding
eye disease. The blockade of retinal ganglion cell apop-
tosis, the reduction of intraocular pressure, and nourish-
ment of the optic nerve are known to be somewhat
Figure 3 Dedifferentiation of retinal stem cells. The stem cells differentiated from retinal Müller cells were transfected with lentivirus
PGC-FU-Atoh7-GFP (A). FACS analysis showed that the transfection efficiency was 75.41% at 48 h after transfection (B). The GFP green
fluorescence could be seen perspicuously in differentiated cells (C). Double immunocytochemical analysis showed that ganglion cells expressed
both Thy1.1 and Brn-3b (D). Scale bar: 100 μm. Ten different visual fields (×100) in each group were selected to count the percentage of
ganglion cells. The percentage of ganglion cells was similar between Group B and Group C (13.3 ± 13.25% versus 9.10 ± 3.21%), but significantly
higher in Group A (50.40 ± 8.22%) (E). At 7 and 14 days, the percentage of ganglion cells was similar (E, F). Apart from ganglion cells, retinal
stem cells differentiated into other type of cells such as amacrine cells, horizontal cells, bipolar cells, photoreceptor cells and Müller cells (G-I).
Scale bar: 100 μm. RT-PCR and Western blot analysis showed that the expression of Atoh7, Brn-3b and Isl-1 was increased after lentivirus
PGC-FU-Atoh7-GFP transfection, but Notch1 expression was slightly decreased (J, K). Lane M: DNA marker; lane 1: groups without transfection;
lane 2: groups with transfection by lentivirus PGC-FU-Atoh7-GFP. FACS, fluorescence-activated cell sorting.
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Figure 4 The percentage of ganglion cells differentiated from retinal stem cells. A. The percentage of ganglion cells differentiated from
retinal stem cells was 23.3 ± 4.45% (group a1), 50.6 ± 7.04% (Group a2) and 49.7 ± 7.36% (Group a3). B. The percentage of ganglion cells
differentiated from retinal stem cells was 25.9 ± 3.35% (Group b1), 49.9 ± 5.38% (Group b2) and 49.2 ± 4.64% (Group b3). C. The percentage of
ganglion cells differentiated from retinal stem cells was 58.2 ± 6.46% (Group c1) and 49.4 ± 5.78% (Group c2). D. Atoh7 and gamma-secretase
inhibitor (GSI) were synergistic to promote the differentiation of retinal stem cells derived from Müller cells into retinal ganglion cells (F = 6.533,
P = 0.005). E. RT-PCR showed that the mRNA expression of Brn-3b, Isl-1 and Notch1 was reduced in Brn-3b siRNA group, Isl-1 siRNA group and
GSI group, respectively, at different time points (0 day, 1 day, 3 days, 7 days, 14 days). Atoh7 and GSI synergistically inhibited mRNA expression
of Notch1.
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retarding disease progression for patients with early glau-
coma or progressing glaucoma. However, such treatment
strategies are ineffective for patients with advanced
glaucoma. This discrepancy lies in the fact that most or
all retinal ganglion cells have undergone apoptosis in
patients with advanced glaucoma, and the number of
surviving ganglion cells is too few to reverse patho-
logical changes resulting from glaucoma. Therefore,
there is an urgent need to develop novel strategies to re-
generate retinal ganglion cells to reverse disease pro-
gression or even restore the vision.
Stem cell engineering has emerged as a promising ap-
proach for retinal regeneration therapy [23,24]. Byincorporating stem cells into the retina and inducing
their proliferation and differentiation into target cells, it
is possible to replenish retinal neurons and restore ret-
inal function. Retinal Müller cells, the glial cells in the
retina, retain proliferation potential and offer an abun-
dant source for cell engineering [9,10]. In addition,
Müller cells span the entire width of the retina and are
widely distributed among ganglion cells. This increases
the chance to better integrate the cells converted from
Müller cells into the ganglion cell layer. All these fea-
tures suggest that retinal Müller cells are the most
promising source of stem cells in the are features sug-
gest that retinal Müller cells are the most promising
source of stem cells in the treatment of glaucoma.
Figure 5 Atoh7 and GSI synergistically inhibit protein expression of Notch1 in retinal stem cells. The protein expression of Brn-3b, Isl-1
and Notch1 was reduced in Brn-3b siRNA group, Isl-1 siRNA group and GSI group, respectively, at different time points (0 day, 1 day, 3 days, 7
days, 14 days). Lane M: DNA marker; lane Con = retinal stem cells untreated; lane S1: retinal stem cells transfected with Brn-3b siRNA and
PGC-FU-Atoh7-GFP; lane NC1: retinal stem cells transfected with scrambled siRNA and PGC-FU-Atoh7-GFP; lane S2: retinal stem cells transfected
with Isl-1 siRNA and PGC-FU-Atoh7-GFP; lane NC2: retinal stem cells transfected with scramble siRNA and PGC-FU-Atoh7-GFP; lane S3: retinal
stem cells treated with GSI and transfected with PGC-FU-Atoh7-GFP; lane NC3: retinal stem cells transfected with PGC-FU-Atoh7-GFP. β–actin
was loading control.
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Müller cells can dedifferentiate into retinal stem cells in
certain conditions, the potential of their differentiation
into ganglion cells remains unclear. Therefore, in the
present study, we selected stem cells dedifferentiated
from rat retinal Müller cells as the target cells. We suc-
cessfully transfected these stem cells with lentivirus
pGC-FU-Atoh7-GFP, and demonstrated that Atoh7
could promote the differentiation of Müller cells derived
stem cells into ganglion cells.
Glutamine synthetase (GS) is a key enzyme that trans-
fers glutamic acid into glutamine and is only expressed
in Müller cells [21]. Therefore, we chose GS as the spe-
cific marker to identify Müller cells. The results showed
that the cells isolated from rat retina displayed the gen-
eral morphology of Müller cells and more than 98.10 ±
2.18% of the cells were immunopositive for GS. FACS
showed that 98.01% of the purified cells were immuno-
reactive for GS. RT-PCR revealed that the cells
expressed a battery of transcripts characteristic of Müller
cells, such as GS, vimentin, CRALBP, clusterin and car-
bonic anhydrase. In contrast, transcripts corresponding
to rod photoreceptors, bipolar cells, amacrine cells, ret-
inal ganglion cells, endothelial cells and RPE/pigmented
ciliary epithelium were not detected. Taken together,
these results demonstrate that our method of purifying
Müller cells is effective.
Currently, two methods are commonly used to induce
the dedifferentiation of retinal Müller cells: one is to use
ouabain, N-methyl-D-aspartate (NMDA) or other agents
to induce the effects of injury, and the other is to add vari-
ous cell growth factors [11-13]. In the present study, we
chose a serum-free DMEM/F12 medium supplemented
with EGF, bFGF and other cytokines to induce the dedif-
ferentiation of retinal Müller cells. Characterization of the
cell spheres dedifferentiated from retinal Müller cells
showed that the cells within the neurospheres highly
expressed retinal stem cell-specific markers Nestin and
Pax6, which, however, are not expressed in normal Müller
cells. Furthermore, positive Edu staining, an important in-
dicator of proliferation, was observed in 82.80 ± 6.65% of
the cells, proving that the cells derived from dedifferenti-
ation have the proliferative ability of stem cells. These data
suggest that upon cytokine stimulation, Müller cells ac-
quire the property of neural stem cells.
The serum is a natural inducer of stem cell differenti-
ation, but previous study showed that stem cells
dedifferentiated from retinal Müller cells did not
undergo neuronal cell differentiation when cultured in
medium only containing serum [25]. BDNF and RA have
been shown to induce neural stem cells to differentiate
into neurons and promote their maturation [26,27].
Thus, we chose to induce re-differentiation of stem cells
by using a culture medium supplemented with BDNFand RA. We found that the stem cells had the ability to
re-differentiate. Cells of various shapes were obtained as
early as at days 7 to 10 of culture. Even without transfec-
tion with Atoh7 expression vector, ganglion cells in-
duced by our medium could account for 9.10 ± 3.21% of
the total differentiated cells.
The directed differentiation of retinal stem cells is
mainly co-regulated by the extracellular microenviron-
ment factors and endogenous cytokines. The bHLH
(basic helix-loop-helix) family plays an important role in
regulating retinal cell differentiation [28]. Atoh7 is a
member of the bHLH family and its expression pattern
is consistent with the spatiotemporal pattern of retinal
ganglion cell differentiation [28]. Atoh7 is a key regula-
tory factor essential for the development of retinal gan-
glion cells in vertebrates [16]. Ectopic expression of
Atoh7 has been shown to increase the number of retinal
ganglion cells differentiated from stem cells [17]. There-
fore, in the present study, we transfected Müller cells-
derived stem cells with the Atoh7 expression vector to
promote the differentiation into ganglion cells. The re-
sults showed that transfection with lentivirus PGC-FU-
Atoh7-GFP led to the differentiation into ganglion cells
at a frequency nearly five times that of transfection with
empty vector, confirming the crucial role of Atoh7 in
promoting the directed differentiation of stem cells into
ganglion cells.
To explore the signaling mechanisms by which Atoh7
promotes the differentiation of Müller cells-derived stem
cells into ganglion cells, we employed the loss of function
approach to intervene with the expression of Brn-3b, Isl-1
and Notch1. Our results showed that knockdown of
Brn-3b or Isl-1 inhibited the differentiation of Müller
cells-derived stem cells into retinal ganglion cells, while
Notch signal pathway inhibitor GSI promoted the diffe-
rentiation into retinal ganglion cells. These results suggest
that Brn-3b and Isl-1 promote while Notch signaling in-
hibits the differentiation of Müller cells-derived stem cells
into retinal ganglion cells. In particular, we found that
overexpression of Atoh7 and inhibition of Notch signaling
by GSI exhibited synergistic effects to promote the dif-
ferentiation into retinal ganglion cells. Considering our re-
sults that Atoh7 inhibited the expression of Notch1, we
propose that Atoh7 promotes the differentiation of retinal
stem cells derived from Müller cells into retinal ganglion
cells by inhibiting Notch signaling.
Conclusions
We established an effective method to isolate and purify
Müller cells from rat retina and successfully induced them
to dedifferentiate into retinal stem cells. Ectopic expres-
sion of Atoh7 promoted the expression of Brn-3b and
Isl-1 but inhibited the expression of Notch1 in these cells.
In addition, knockdown of Brn-3b or Isl-1 inhibited, while
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retinal ganglion cells. These data suggest that Atoh7 pro-
motes the differentiation of Müller cells-derived retinal
stem cells into retinal ganglion cells by inhibiting Notch
signaling, and open up a new avenue for gene therapy and
optic nerve regeneration in glaucoma.
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